Literature DB >> 9065433

Dimerization and activation of the herpes simplex virus type 1 protease.

U Schmidt1, P L Darke.   

Abstract

The quaternary state of the herpes simplex virus type 1 (HSV-1) protease has been analyzed in relation to its catalytic activity. The dependence of specific activity upon enzyme concentration indicated that association of the 27-kDa subunits strongly increased activity. Size-exclusion chromatography identified the association as a monomer-dimer equilibrium. Isolation of monomeric and dimeric species from a size-exclusion column followed by immediate assay identified the dimer as the active form of the enzyme. Activation of the protease by antichaotropic cosolvents correlated with changes in the monomer-dimer equilibrium. Thus, dimerization of the enzyme was enhanced in solvents containing glycerol or the anions citrate or phosphate. These are substances previously identified as activators of HSV-1 protease (Hall, D. L., and Darke, P. L. (1995) J. Biol. Chem. 270, 22697-22700). The relative potencies of these cosolvents as enzyme activators correlated with their efficiency in promoting dimerization. Under all solvent conditions examined, the dependence of specific activity upon enzyme concentration was consistent with a kinetic model in which only the dimer is active. Dissociation constants for the HSV-1 protease dimer determined with this model at 15 degrees C, pH 7.5, were 964 and 225 nM in 20% glycerol with 0.2 and 0.5 M citrate present, respectively. The activation of the HSV-1 protease by antichaotropic cosolvents was hereby shown to be similar in nature to the activation of the other well characterized herpesvirus protease, that from human cytomegalovirus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065433     DOI: 10.1074/jbc.272.12.7732

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  The Prohead-I structure of bacteriophage HK97: implications for scaffold-mediated control of particle assembly and maturation.

Authors:  Rick K Huang; Reza Khayat; Kelly K Lee; Ilya Gertsman; Robert L Duda; Roger W Hendrix; John E Johnson
Journal:  J Mol Biol       Date:  2011-01-27       Impact factor: 5.469

Review 2.  Virus maturation.

Authors:  David Veesler; John E Johnson
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

3.  Mechanism and specificity of the human paracaspase MALT1.

Authors:  Janna Hachmann; Scott J Snipas; Bram J van Raam; Erik M Cancino; Emily J Houlihan; Marcin Poreba; Paulina Kasperkiewicz; Marcin Drag; Guy S Salvesen
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

4.  Substrate modulation of enzyme activity in the herpesvirus protease family.

Authors:  Ana Lazic; David H Goetz; Anson M Nomura; Alan B Marnett; Charles S Craik
Journal:  J Mol Biol       Date:  2007-08-16       Impact factor: 5.469

Review 5.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

6.  The bacteriophage lambda gpNu3 scaffolding protein is an intrinsically disordered and biologically functional procapsid assembly catalyst.

Authors:  Eva Margarita Medina; Benjamin T Andrews; Eri Nakatani; Carlos Enrique Catalano
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

7.  Common Evolutionary Origin of Procapsid Proteases, Phage Tail Tubes, and Tubes of Bacterial Type VI Secretion Systems.

Authors:  Andrei Fokine; Michael G Rossmann
Journal:  Structure       Date:  2016-09-22       Impact factor: 5.006

8.  Inhibition of a viral enzyme by a small-molecule dimer disruptor.

Authors:  Tina Shahian; Gregory M Lee; Ana Lazic; Leggy A Arnold; Priya Velusamy; Christina M Roels; R Kiplin Guy; Charles S Craik
Journal:  Nat Chem Biol       Date:  2009-07-26       Impact factor: 15.040

9.  Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor.

Authors:  Alan B Marnett; Anson M Nomura; Nobuhisa Shimba; Paul R Ortiz de Montellano; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

10.  Activation of caspases-8 and -10 by FLIP(L).

Authors:  Kelly M Boatright; Cristina Deis; Jean-Bernard Denault; Daniel P Sutherlin; Guy S Salvesen
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.